{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T22:34:27Z","timestamp":1774564467259,"version":"3.50.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T00:00:00Z","timestamp":1684368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T00:00:00Z","timestamp":1684368000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100008158","name":"Arthritis Foundation of Western Australia","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100008158","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001063","name":"Raine Medical Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001063","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012505","name":"Royal Perth Hospital Medical Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012505","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Ada Bartholomew Trust"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Musculoskelet Disord"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Patients with rheumatoid arthritis (RA) have shown increased levels of neutrophils generating kallikrein-kinin peptides in blood which are potent mediators of inflammation. This study investigated the association between the bioregulation of kinin-mediated inflammation with the clinical, quality of life, and imaging characteristics (e.g. ultrasonography) of different arthritides.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Patients with osteoarthritis (OA,\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200929), gout (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200910) and RA (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20098) were recruited and screened for clinical symptoms, quality of life, and ultrasonographical assessment of arthritis. Blood neutrophils were assessed for the expression of bradykinin receptors (B1R and B2R), kininogens and kallikreins by immunocytochemistry with visualization by bright field microscopy. Levels of plasma biomarkers were measured by ELISA and cytometric bead array.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Quality of life (SF-36 domains and summary scores; including pain; and, HAQ) was similar across OA, gout and RA patients; with the exception of worse physical functioning scores between OA and gout patients. Synovial hypertrophy (on ultrasound) differed between groups (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.001), and the dichotomised Power Doppler (PD) score of greater than or equal to 2 (PD-GE2) was marginally significant (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.09). Plasma IL-8 were highest in patients with gout followed by RA and OA (both,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.05). Patients with RA had higher plasma levels of sTNFR1, IL-1\u03b2, IL-12p70, TNF and IL-6, compared to OA and gout patients (all,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.05). Patients with OA had higher expression of K1B and KLK1\u00a0on blood neutrophils followed by RA and gout patients (both,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.05). Bodily pain correlated with B1R expression on blood neutrophils (\n                      <jats:italic>r<\/jats:italic>\n                      \u2009=\u20090.334,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.05), and inversely with plasma levels of CRP (\n                      <jats:italic>r<\/jats:italic>\n                      \u2009=\u2009\u22120.55), sTNFR1 (\n                      <jats:italic>r<\/jats:italic>\n                      \u2009=\u2009\u22120.352) and IL-6 (\n                      <jats:italic>r<\/jats:italic>\n                      \u2009=\u2009\u22120.422), all\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.05. Expression of B1R on blood neutrophils also correlated with Knee PD (\n                      <jats:italic>r<\/jats:italic>\n                      \u2009=\u20090.403) and PD-GE2 (\n                      <jats:italic>r<\/jats:italic>\n                      \u2009=\u20090.480), both\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.05.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Pain levels and quality of life were similar between patients with OA, RA and gout with knee arthritis. Plasma inflammatory biomarkers and B1R expression on blood neutrophils correlated with pain. Targeting B1R to modulate the kinin-kallikrein system may pose as a new therapeutic target in the treatment of arthritis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12891-023-06388-9","type":"journal-article","created":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T04:03:15Z","timestamp":1684382595000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["The relationship between clinical phenotype and kallikrein-kinin bioregulation in different forms of arthritis"],"prefix":"10.1186","volume":"24","author":[{"given":"Dino B. A.","family":"Tan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chantalia","family":"Tedja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lukas","family":"Kuster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Warren D.","family":"Raymond","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreea","family":"Harsanyi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Priya V.","family":"Chowalloor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neil L.","family":"Misso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shashi","family":"Argawal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kanti D.","family":"Bhoola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen I.","family":"Keen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,5,18]]},"reference":[{"key":"6388_CR1","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1186\/1471-2474-16-S1-S3","volume":"16","author":"AD Woolf","year":"2015","unstructured":"Woolf AD. Global burden of osteoarthritis and musculoskeletal diseases. BMC Musculoskelet Disord. 2015;16:S3.","journal-title":"BMC Musculoskelet Disord"},{"key":"6388_CR2","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/0049-0172(89)90013-9","volume":"18","author":"HG Schaible","year":"1989","unstructured":"Schaible HG, Neugebauer V, Schmidt RF. Osteoarthritis and pain. Semin Arthritis Rheum. 1989;18:30\u20134.","journal-title":"Semin Arthritis Rheum"},{"key":"6388_CR3","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.rdc.2004.09.004","volume":"31","author":"H-G Schaible","year":"2005","unstructured":"Schaible H-G, Del Rosso A, Matucci-Cerinic M. Neurogenic aspects of inflammation. Rheum Dis Clin North Am. 2005;31:77\u2013101.","journal-title":"Rheum Dis Clin North Am"},{"key":"6388_CR4","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.addr.2006.01.011","volume":"58","author":"H-G Schaible","year":"2006","unstructured":"Schaible H-G, Schmelz M, Tegeder I. Pathophysiology and treatment of pain in joint disease. Adv Drug Deliv Rev. 2006;58:323\u201342.","journal-title":"Adv Drug Deliv Rev"},{"key":"6388_CR5","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1093\/rheumatology\/36.7.726","volume":"36","author":"P Creamer","year":"1997","unstructured":"Creamer P, Hochberg MC. Why does osteoarthritis of the knee hurt\u2013sometimes? Br J Rheumatol. 1997;36:726\u20138.","journal-title":"Br J Rheumatol"},{"key":"6388_CR6","first-page":"1031","volume":"23","author":"P Creamer","year":"1996","unstructured":"Creamer P, Hunt M, Dieppe P. Pain mechanisms in osteoarthritis of the knee: effect of intraarticular anesthetic. J Rheumatol. 1996;23:1031\u20136.","journal-title":"J Rheumatol"},{"key":"6388_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0163-7258(02)00166-3","volume":"94","author":"B Cassim","year":"2002","unstructured":"Cassim B, Mody G, Bhoola KD. Kallikrein cascade and cytokines in inflamed joints. Pharmacol Ther. 2002;94:1\u201334.","journal-title":"Pharmacol Ther"},{"key":"6388_CR8","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1093\/rheumatology\/kep016","volume":"48","author":"B Cassim","year":"2009","unstructured":"Cassim B, Shaw OM, Mazur M, Misso NL, Naran A, Langlands DR, et al. Kallikreins, kininogens and kinin receptors on circulating and synovial fluid neutrophils: role in kinin generation in rheumatoid arthritis. Rheumatology. 2009;48:490\u20136.","journal-title":"Rheumatology"},{"key":"6388_CR9","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1093\/rheumatology\/31.8.509","volume":"31","author":"K Bhoola","year":"1992","unstructured":"Bhoola K, Elson C, Dieppe P. Kinins\u2014key mediators in inflammatory arthritis? Rheumatology. 1992;31:509\u201318.","journal-title":"Rheumatology"},{"key":"6388_CR10","doi-asserted-by":"publisher","first-page":"234","DOI":"10.2174\/187152509789105444","volume":"7","author":"JW Bryant","year":"2009","unstructured":"Bryant JW, Shariat-Madar Z. Human plasma kallikrein-kinin system: physiological and biochemical parameters. Cardiovasc Hematol Agents Med Chem. 2009;7:234\u201350.","journal-title":"Cardiovasc Hematol Agents Med Chem"},{"key":"6388_CR11","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1136\/ard.2007.080382","volume":"68","author":"IH Song","year":"2009","unstructured":"Song IH, Althoff CE, Hermann KG, Scheel AK, Knetsch T, Burmester GR, et al. Contrast-enhanced ultrasound in monitoring the efficacy of a bradykinin receptor 2 antagonist in painful knee osteoarthritis compared with MRI. Ann Rheum Dis. 2009;68:75\u201383.","journal-title":"Ann Rheum Dis"},{"key":"6388_CR12","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/s00011-007-7204-1","volume":"57","author":"S Meini","year":"2008","unstructured":"Meini S, Maggi CA. Knee osteoarthritis: a role for bradykinin? Inflamm Res. 2008;57:351\u201361.","journal-title":"Inflamm Res"},{"key":"6388_CR13","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.bbrc.2011.10.137","volume":"416","author":"OM Shaw","year":"2011","unstructured":"Shaw OM, Harper JL. Bradykinin receptor 2 extends inflammatory cell recruitment in a model of acute gouty arthritis. Biochem Biophys Res Commun. 2011;416:266\u20139.","journal-title":"Biochem Biophys Res Commun"},{"key":"6388_CR14","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1002\/art.1780340205","volume":"34","author":"B Haraoui","year":"1991","unstructured":"Haraoui B, Pelletier JP, Cloutier JM, Faure MP, Martel-Pelletier J. Synovial membrane histology and immunopathology in rheumatoid arthritis and osteoarthritis. In vivo effects of antirheumatic drugs. Arthritis Rheum. 1991;34:153\u201363.","journal-title":"Arthritis Rheum"},{"key":"6388_CR15","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1002\/art.1780090302","volume":"9","author":"JB Peter","year":"1966","unstructured":"Peter JB, Pearson CM, Marmor L. Erosive osteoarthritis of the hands. Arthritis Rheum. 1966;9:365\u201388.","journal-title":"Arthritis Rheum"},{"key":"6388_CR16","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1002\/art.1780290816","volume":"29","author":"R Altman","year":"1986","unstructured":"Altman R, Asch E, Bloch D, Bole G, Borenstein D, Brandt K, et al. Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. Arthritis Rheum. 1986;29:1039\u201349.","journal-title":"Arthritis Rheum"},{"key":"6388_CR17","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1136\/ard.2010.138461","volume":"69","author":"D Aletaha","year":"2010","unstructured":"Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO 3rd, et al. 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative. Ann Rheum Dis. 2010;69:1580\u20138.","journal-title":"Ann Rheum Dis"},{"key":"6388_CR18","unstructured":"Bellamy N, Buchanan W, Goldsmith C, Campbell J, Stitt L, Campbell J, et al. Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes following total hip and knee arthroplasty in osteoarthritis. 1988."},{"key":"6388_CR19","volume-title":"SF-36 health survey manual & interpretation guide","author":"JE Ware","year":"2002","unstructured":"Ware JE, Kosinski MA, Gandek B. SF-36 health survey manual & interpretation guide. Lincoln: QualityMetric Inc; 2002."},{"key":"6388_CR20","first-page":"S14","volume":"23","author":"B Bruce","year":"2005","unstructured":"Bruce B, Fries JF. The health assessment questionnaire (HAQ). Clin Exp Rheumatol. 2005;23:S14-18.","journal-title":"Clin Exp Rheumatol"},{"key":"6388_CR21","doi-asserted-by":"publisher","first-page":"e000428","DOI":"10.1136\/rmdopen-2016-000428","volume":"3","author":"M-A D\u2019Agostino","year":"2017","unstructured":"D\u2019Agostino M-A, Terslev L, Aegerter P, Backhaus M, Balint P, Bruyn GA, et al. Scoring ultrasound synovitis in rheumatoid arthritis: a EULAR-OMERACT ultrasound taskforce\u2014Part 1: definition and development of a standardised, consensus-based scoring system. RMD Open. 2017;3:e000428.","journal-title":"RMD Open"},{"key":"6388_CR22","doi-asserted-by":"publisher","first-page":"e000427","DOI":"10.1136\/rmdopen-2016-000427","volume":"3","author":"L Terslev","year":"2017","unstructured":"Terslev L, Naredo E, Aegerter P, Wakefield RJ, Backhaus M, Balint P, et al. Scoring ultrasound synovitis in rheumatoid arthritis: a EULAR-OMERACT ultrasound taskforce-Part 2: reliability and application to multiple joints of a standardised consensus-based scoring system. RMD Open. 2017;3:e000427.","journal-title":"RMD Open"},{"key":"6388_CR23","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.cyto.2014.06.019","volume":"70","author":"RE Miller","year":"2014","unstructured":"Miller RE, Miller RJ, Malfait AM. Osteoarthritis joint pain: the cytokine connection. Cytokine. 2014;70:185\u201393.","journal-title":"Cytokine"},{"key":"6388_CR24","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1038\/nrrheum.2010.159","volume":"6","author":"J Sellam","year":"2010","unstructured":"Sellam J, Berenbaum F. The role of synovitis in pathophysiology and clinical symptoms of osteoarthritis. Nat Rev Rheumatol. 2010;6:625\u201335.","journal-title":"Nat Rev Rheumatol"},{"key":"6388_CR25","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1038\/nrd1522","volume":"3","author":"F Marceau","year":"2004","unstructured":"Marceau F, Regoli D. Bradykinin receptor ligands: therapeutic perspectives. Nat Rev Drug Discov. 2004;3:845\u201352.","journal-title":"Nat Rev Drug Discov"},{"key":"6388_CR26","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1254\/jphs.SRJ05001X","volume":"99","author":"ME Moreau","year":"2005","unstructured":"Moreau ME, Garbacki N, Molinaro G, Brown NJ, Marceau F, Adam A. The kallikrein-kinin system: current and future pharmacological targets. J Pharmacol Sci. 2005;99:6\u201338.","journal-title":"J Pharmacol Sci"},{"key":"6388_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0306-3623(96)00174-7","volume":"28","author":"JM Hall","year":"1997","unstructured":"Hall JM. Bradykinin receptors. Gen Pharmacol. 1997;28:1\u20136.","journal-title":"Gen Pharmacol"},{"key":"6388_CR28","doi-asserted-by":"publisher","first-page":"R76","DOI":"10.1186\/ar3338","volume":"13","author":"GN Kaufman","year":"2011","unstructured":"Kaufman GN, Zaouter C, Valteau B, Sirois P, Moldovan F. Nociceptive tolerance is improved by bradykinin receptor B1 antagonism and joint morphology is protected by both endothelin type A and bradykinin receptor B1 antagonism in a surgical model of osteoarthritis. Arthritis Res Ther. 2011;13:R76.","journal-title":"Arthritis Res Ther"}],"container-title":["BMC Musculoskeletal Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-023-06388-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12891-023-06388-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-023-06388-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T04:04:34Z","timestamp":1684382674000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmusculoskeletdisord.biomedcentral.com\/articles\/10.1186\/s12891-023-06388-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,18]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["6388"],"URL":"https:\/\/doi.org\/10.1186\/s12891-023-06388-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2323715\/v1","asserted-by":"object"}]},"ISSN":["1471-2474"],"issn-type":[{"value":"1471-2474","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,18]]},"assertion":[{"value":"29 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethics Committee of Royal Perth Hospital, and informed consent was obtained from all subjects. The study was conducted in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"396"}}